UK Health Security Agency launches to address ‘future health threats’
New national agency will plan for, prevent and respond to external health threats including infectious diseases
Read More
Tag: Pandemic response
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
- Theolytics announces first patient dosed in the Octopod‑IP trial
- UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
- Saphnelo approved in the US for subcutaneous self‑administration
- Transgene completes randomisation in phase 2 trial of tg4050
